Cytocom, Inc. Announces Plan to Adopt New Corporate Name “Statera BioPharma, Inc.”

Cytocom, Inc. (Nasdaq: CBLI), a leading biopharmaceutical company creating next-generation immune therapies that focus on immune restoration and homeostasis, today announced plans to change its corpor...

Learn More

Heads Up Health Extends Seed Round to $2.25M Led by Innosphere Ventures

 Innosphere Ventures’ seed-stage venture capital fund has announced its second investment into Heads Up Health (Heads Up) which gives Heads Up the ability to close out their seed round at $2.25 millio...

Learn More

CSURF announces the departure of Todd Headley, VP of Technology Transfer

It is with mixed emotions that CSURF announces the departure of Todd Headley, Vice President of Technology Transfer.  Todd’s contributions and impact at CSURF and Colorado State University have b...

Learn More

SomaLogic Closes Business Combination and Will Begin Trading Under the Ticker “SLGC” on the Nasdaq Stock Exchange

SomaLogic, Inc., a leader in AI-data driven proteomics technology, today announced that it has completed its business combination with CM Life Sciences II, Inc. (Nasdaq: CMIIU), a special purpose acqu...

Learn More

Zalgen Awarded CEPI Contract to Provide Test Kits for Largest Ever Lassa Fever Study in West Africa

Zalgen Labs LLC (Zalgen), a biotechnology and diagnostics company focused on preparedness for high impact, neglected infectious diseases including Lassa Fever (LF), today announced its contract with t...

Learn More

PharmaJet Partner Zydus Cadila Announces Emergency Use Authorization Approval for World’s First Plasmid DNA COVID-19 Vaccine

Vaccine delivered exclusively with the PharmaJet Needle-free System GOLDEN, Colo.- PharmaJet®, the maker of innovative, needle-free injection technology, today announced that its partner, Zydus Cadila...

Learn More

Golden-based BioIntelliSense ramps up with $45M in financing to scale vital-monitoring sticker

The Golden-based company received FDA approval and insurance reimbursement approval for a remote monitoring wearable that can continuously collect vital signs data from a patient. Find out more in the...

Learn More

Edgewise Receives U.S. FDA Fast Track Designation for EDG-5506 for the Treatment of Individuals with Becker Muscular Dystrophy (BMD)

Edgewise Therapeutics, Inc., (NASDAQ: EWTX), a clinical-stage biopharmaceutical company focused on developing orally bioavailable, small molecule therapies for rare muscle disorders, today announced t...

Learn More

KromaTiD Appoints Nathan Wood as Chief Executive Officer

KromaTiD, Inc. announces that Nathan Wood, will be joining as its Chief Executive Officer. Wood is a seasoned executive with thirty years of experience in the life science industry and is the for...

Learn More

Fitzsimons Innovation Community Accelerates Growth

Breaks ground on first full-scale commercial manufacturing facility, for cell and gene therapy AURORA, Colo. (August 12, 2021) – Today, Fitzsimons Innovation Community breaks ground on its new bioscie...

Learn More